Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Stock Short Interest Falls 50.2%

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) saw a significant drop in short interest in the month of October. As of October 15th, there was short interest totaling 82,052 shares, a drop of 50.2% from the September 30th total of 164,782 shares. Based on an average trading volume of 94,563 shares, the days-to-cover ratio is presently 0.9 days. Currently, 1.3% of the shares of the stock are sold short.

Analysts Set New Price Targets

Several analysts have issued reports on CELZ shares. Wall Street Zen upgraded shares of Creative Medical Technology from a “sell” rating to a “hold” rating in a research report on Saturday, September 12th. Roth Capital reissued a “buy” rating on shares of Creative Medical Technology in a research note on Thursday, August 20th. Finally, Weiss Ratings cut Creative Medical Technology from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, September 24th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Creative Medical Technology Trading Down 5.2%

NASDAQ CELZ traded down $0.03 on Monday, hitting $0.62. 161,175 shares of the company traded hands, compared to its average volume of 3,065,898. The company has a market capitalization of $4.09 million, a price-to-earnings ratio of -0.30 and a beta of 2.06. The business’s 50 day moving average price is $0.93 and its 200-day moving average price is $1.57. Creative Medical Technology has a 52-week low of $0.60 and a 52-week high of $4.72.

Creative Medical Technology (NASDAQ:CELZ) last posted its earnings results on Friday, August 7th. The company reported ($0.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.02). As a group, sell-side analysts predict that Creative Medical Technology will post -1.18 earnings per share for the current year.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc is a biotechnology company focused on developing regenerative medicine and cellular therapies. Its research programs are designed to use stem cells and other biological approaches to address conditions for which existing treatment options may be limited.

The company has developed and investigated therapies based on autologous stem cells, meaning cells collected from and administered back to the same patient. Its programs have included CaverStem, a regenerative treatment candidate for erectile dysfunction, as well as investigational platforms such as FemCelz for female sexual dysfunction and ImmCelz, an immune-modulating cellular therapy platform.